Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal Carcinoma
A phase 2 trial of Temoporfin in Nasopharyngeal carcinoma, run by Ministry of Health, Malaysia, with a status the registry has not verified recently.
Overview
Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal Carcinoma is a phase 2 interventional study registered as NCT01086488 by Ministry of Health, Malaysia, with 66 participants planned, started 2009-01 and due to reach its primary completion in 2011-09. Interventions recorded: FOSCAN. Conditions recorded: Nasopharyngeal Carcinoma.
Linked to the drug Temoporfin because the registry names it among its interventions and Nasopharyngeal carcinoma among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialInterstitial Photodynamic Therapy (PDT) With Temoporfin for Advanced Head and Neck Cancers
Shares Temoporfin and the tag pipeline.
- TrialSafety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers
Shares Temoporfin and the tag pipeline.
- TrialAutologous Dendritic Cells and Allogenic Dendritic Secretomes for Patients With Advanced Nasopharyngeal Cancer
Shares Nasopharyngeal carcinoma and the tag pipeline.
- TrialA Phase II Study to Evaluate HLX43 in Subjects With Recurrent/Metastatic Nasopharyngeal Carcinoma Failed or Intolerance to Second-line Therapy
Shares Nasopharyngeal carcinoma and the tag pipeline.
- TrialAVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Shares Nasopharyngeal carcinoma and the tag pipeline.
- TreatmentKL-A167
Shares Nasopharyngeal carcinoma and the tag pipeline.
- TreatmentMRG003
Shares Nasopharyngeal carcinoma and the tag pipeline.
- TreatmentHMBD-001
Shares Nasopharyngeal carcinoma and the tag pipeline.